Viewing Study NCT05853692


Ignite Creation Date: 2025-12-24 @ 3:35 PM
Ignite Modification Date: 2026-01-04 @ 7:56 AM
Study NCT ID: NCT05853692
Status: RECRUITING
Last Update Posted: 2023-05-11
First Post: 2023-04-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Prevention of Oral Mucositis in Head and Neck Cancer.
Sponsor: Catholic University of the Sacred Heart
Organization:

Study Overview

Official Title: Prevention of Oral Mucositis in Subjects Undergoing Radiotherapy for Head and Neck Cancer. A Randomized Clinical Trial.
Status: RECRUITING
Status Verified Date: 2023-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: OMHNC-1
Brief Summary: Oral Mucositis (OM) consists in the painful inflammation and ulceration of the mucous membranes lining the digestive tract, lasting between 7 and 98 days; and starts as an acute inflammation of oral mucosa, tongue, and pharynx after RT exposure.

Gel X spray is a product based on zinc gluconate. It could be helpful to achieve the prevention of Oral Mucositis and, in case of OM manifestation, the reduction of oral pain symptoms and to accelerate the healing process of oral mucositis ulcerations.

The aim of this study is to demonstrate the efficacy of the treatment with Gel X to reduce the incidence of oral mucositis, in comparison with Sodium Bicarbonate.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: